People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cerapedics Inc | — | Biotechnology | Series B | $99.1M | $492.3M | 2018 |
Drew J. Trivisonno at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Drew J. Trivisonno on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Silverstein | 1 | 10 |
| Chau Khuong | 1 | 9 |
| Tyrell Rivers | 1 | 6 |
| Noah Kroloff | 1 | 6 |
| Chen Schor | 1 | 4 |
| Antony Koblish | 1 | 3 |
| Glen Kashuba | 1 | 3 |
| Ken Abramowitz | 1 | 2 |
| Paul J. Mraz | 1 | 1 |
| Chau J. Khuong | 1 | 1 |
| Samuel S. Wu | 1 | 1 |
| Leonard Habas | 1 | 1 |
| Leonard J. Habas | 1 | 1 |
| Andrew J. Handwerker | 1 | 1 |
| Ken S. Abramowitz | 1 | 1 |
| Britt S. Pearson | 1 | 1 |
| Jeff S. Marx | 1 | 1 |
| Andrew J Tofe | 1 | 1 |
| Jerome S. Connor | 1 | 1 |
| Chen J. Schor | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.